Birgens H - Search Results

1

Need for reclassification of diabetes secondary to iron overload in the ADA and WHO classifications.

Ellervik C, Birgens H, Mandrup-Poulsen T. Ellervik C, et al. Among authors: birgens h. Diabetes Care. 2014 Jun;37(6):e137-8. doi: 10.2337/dc14-0119. Diabetes Care. 2014. PMID: 24855170 No abstract available.

2

Elevated transferrin saturation and risk of diabetes: three population-based studies.

Ellervik C, Mandrup-Poulsen T, Andersen HU, Tybjærg-Hansen A, Frandsen M, Birgens H, Nordestgaard BG. Ellervik C, et al. Among authors: birgens h. Diabetes Care. 2011 Oct;34(10):2256-8. doi: 10.2337/dc11-0416. Epub 2011 Aug 26. Diabetes Care. 2011. PMID: 21873562 Free PMC article.

3

Total mortality by elevated transferrin saturation in patients with diabetes.

Ellervik C, Andersen HU, Tybjærg-Hansen A, Frandsen M, Birgens H, Nordestgaard BG, Mandrup-Poulsen T. Ellervik C, et al. Among authors: birgens h. Diabetes Care. 2013 Sep;36(9):2646-54. doi: 10.2337/dc12-2032. Epub 2013 Jun 25. Diabetes Care. 2013. PMID: 23801727 Free PMC article.

4

Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study.

Ellervik C, Mandrup-Poulsen T, Nordestgaard BG, Larsen LE, Appleyard M, Frandsen M, Petersen P, Schlichting P, Saermark T, Tybjaerg-Hansen A, Birgens H. Ellervik C, et al. Among authors: birgens h. Lancet. 2001 Oct 27;358(9291):1405-9. doi: 10.1016/S0140-6736(01)06526-6. Lancet. 2001. PMID: 11705485

5

Hemochromatosis genotypes and risk of 31 disease endpoints: meta-analyses including 66,000 cases and 226,000 controls.

Ellervik C, Birgens H, Tybjaerg-Hansen A, Nordestgaard BG. Ellervik C, et al. Among authors: birgens h. Hepatology. 2007 Oct;46(4):1071-80. doi: 10.1002/hep.21885. Hepatology. 2007. PMID: 17828789

6

[Prevalence of hemochromatosis-associated mutations in the hemochromatosis gene in the Danish population].

Larsen LE, Ellervik C, Appleyard M, Nordestgaard BG, Birgens H, Tybjaerg-Hansen A. Larsen LE, et al. Among authors: birgens h. Ugeskr Laeger. 2002 Sep 23;164(39):4545-7. Ugeskr Laeger. 2002. PMID: 12380399 Danish.

7

[On the response "The scientific basis for the assessment of medical technology"].

Birgens H, Jacobsen IA, Krarup T, Madsen JR, Aldershvile J, Mandrup-Poulsen T. Birgens H, et al. Ugeskr Laeger. 1996 Dec 30;159(1):64-7. Ugeskr Laeger. 1996. PMID: 9012078 Danish. No abstract available.

8

Hemochromatosis mutations in the general population: iron overload progression rate.

Andersen RV, Tybjaerg-Hansen A, Appleyard M, Birgens H, Nordestgaard BG. Andersen RV, et al. Among authors: birgens h. Blood. 2004 Apr 15;103(8):2914-9. doi: 10.1182/blood-2003-10-3564. Epub 2003 Dec 4. Blood. 2004. PMID: 15070663 Free article.

9

The JAK2 V617F somatic mutation, mortality and cancer risk in the general population.

Nielsen C, Birgens HS, Nordestgaard BG, Kjaer L, Bojesen SE. Nielsen C, et al. Haematologica. 2011 Mar;96(3):450-3. doi: 10.3324/haematol.2010.033191. Epub 2010 Dec 15. Haematologica. 2011. PMID: 21160067 Free PMC article.

10

Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia.

Toft N, Birgens H, Abrahamsson J, Griškevičius L, Hallböök H, Heyman M, Klausen TW, Jónsson ÓG, Palk K, Pruunsild K, Quist-Paulsen P, Vaitkeviciene G, Vettenranta K, Åsberg A, Frandsen TL, Marquart HV, Madsen HO, Norén-Nyström U, Schmiegelow K. Toft N, et al. Among authors: birgens h. Leukemia. 2018 Mar;32(3):606-615. doi: 10.1038/leu.2017.265. Epub 2017 Aug 18. Leukemia. 2018. PMID: 28819280

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters